ストックスクリーナーアプリを入手
92.64
0.84%
-0.74
前日終値:
$93.38
開ける：
$93.8
24時間の取引高:
153.23K
Relative Volume:
0.12
時価総額：
$10.75B
収益：
$2.77B
当期純損益:
$286.61M
株価収益率:
39.42
EPS:
2.35
ネットキャッシュフロー:
$524.11M
1週間 パフォーマンス:
+5.65%
1か月 パフォーマンス:
+6.88%
6か月 パフォーマンス:
-3.70%
1年 パフォーマンス:
-24.43%
1日の値動き範囲:
$92.43
$94.64
1週間の範囲:
$87.55
$94.92
52週間の値動き範囲:
$81.36
$129.50
Revvity Inc Stock (RVTY) Company Profile
RVTY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
92.64 | 10.84B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
541.95 | 205.40B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
209.61 | 151.60B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
626.84 | 50.23B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.87 | 40.15B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
202.92 | 34.85B | 15.70B | 1.24B | 2.01B | 6.9036 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-01 | アップグレード | UBS | Neutral → Buy |
| 2025-01-10 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Equal Weight |
| 2024-07-08 | 開始されました | Leerink Partners | Outperform |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-01-16 | ダウングレード | UBS | Buy → Neutral |
| 2024-01-04 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-05-23 | 再開されました | Goldman | Buy |
すべてを表示
Revvity Inc (RVTY) 最新ニュース
Revvity to Hold Earnings Call on Monday, October 27, 2025 - PharmiWeb.com
Revvity, Sanofi team on early Type 1 detection; Kihealth raises funds for diabetes test rollout - MedTech Dive
Is Revvity Inc. stock undervalued vs historical averagesBuy Signal & Community Verified Trade Alerts - newser.com
Is Revvity Inc. stock a top pick for value investorsMarket Growth Report & Fast Momentum Entry Tips - newser.com
How Revvity Inc. (PKN) stock reacts to Fed tightening2025 Key Highlights & Weekly High Return Opportunities - newser.com
Revvity Inc. stock trend outlook and recovery pathBreakout Watch & Comprehensive Market Scan Reports - newser.com
What drives Revvity Inc stock priceShort-Term Trading Alerts & These Picks Are Just One Breakout Away - earlytimes.in
Can a trend reversal in Revvity Inc. lead to recoveryChart Signals & Stock Timing and Entry Methods - newser.com
Using AI based signals to follow Revvity Inc.Trade Volume Report & Risk Controlled Daily Trade Plans - newser.com
Chart based analysis of Revvity Inc. trends2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Revvity to develop type 1 diabetes early detection assay with Sanofi - Investing.com Nigeria
Automated trading signals detected on Revvity Inc.Trade Signal Summary & Safe Entry Trade Signal Reports - newser.com
Order flow analysis tools used on Revvity Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Will Revvity Inc. (PKN) stock enhance shareholder valueDay Trade & Expert Approved Trade Ideas - newser.com
Lucem, Revvity partner with Sanofi for early T1D detection - BioWorld MedTech
Barclays Adjusts Revvity (RVTY) Price Target, Maintains Overweig - GuruFocus
Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes - PharmiWeb.com
Barclays Maintains Revvity (RVTY) Overweight Recommendation - Nasdaq
Revvity Expands Type 1 Diabetes Program With Sanofi Support - Nasdaq
Sanofi (SNY) Supports Revvity's Expansion in Type 1 Diabetes Assay - GuruFocus
Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering - MarketScreener
Barclays Adjusts Price Target on Revvity to $100 From $110, Maintains Overweight Rating - MarketScreener
Barclays Maintains Revvity(RVTY.US) With Buy Rating, Cuts Target Price to $100 - 富途牛牛
Will Revvity Inc. stock sustain high P E ratiosJuly 2025 PostEarnings & Daily Price Action Insights - newser.com
Bruker, Agilent, Revvity, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - The Globe and Mail
Revvity Launches AI Software Transforming Preclinical Imaging - Precedence Research
How to recover losses in Revvity Inc. stockRate Cut & High Conviction Buy Zone Alerts - newser.com
Revvity Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener
Revvity (RVTY) Unveils Advanced AI Imaging Software for Researchers - GuruFocus
Revvity launches AI-powered multimodal analysis software for imaging research By Investing.com - Investing.com South Africa
Revvity launches AI-powered multimodal analysis software for imaging research - Investing.com
Revvity, Inc. Unveils New AI Software Offering to Transform Preclinical Imaging Analysis - MarketScreener
Should You Think About Buying Revvity, Inc. (NYSE:RVTY) Now? - Yahoo Finance
Revvity Inc PKN Stock Analysis and ForecastMarket Sentiment Shifts & Affordable Portfolio Trading - earlytimes.in
Is Revvity Inc PKN a good long term investmentDouble Top/Bottom Patterns & High Return Portfolio Growth - earlytimes.in
What analysts say about Revvity Inc stockGlobal Trade Effects & Affordable Trading Strategies - earlytimes.in
Published on: 2025-09-27 18:11:56 - newser.com
Revvity Inc (RVTY) 財務データ
収益
当期純利益
現金流量
EPS
0.92%
1.45%
大文字化:
|
ボリューム (24 時間):